A versatile drug delivery system targeting senescent cells
Open accessThe DOI matches its Crossref record; 64 of the 64 references it cites were found in a registry or an index.
Abstract
Senescent cells accumulate in multiple aging‐associated diseases, and eliminating these cells has recently emerged as a promising therapeutic approach. Here, we take advantage of the high lysosomal β‐galactosidase activity of senescent cells to design a drug delivery system based on the encapsulation of drugs with galacto‐oligosaccharides. We show that gal‐encapsulated fluorophores are preferentially released within senescent cells in mice. In a model of chemotherapy‐induced senescence, gal‐encapsulated cytotoxic drugs target senescent tumor cells and improve tumor xenograft regression in combination with palbociclib. Moreover, in a model of pulmonary fibrosis in mice, gal‐encapsulated cytotoxics target senescent cells, reducing collagen deposition and restoring pulmonary function. Finally, gal‐encapsulation reduces the toxic side effects of the cytotoxic drugs. Drug delivery into senescent cells opens new diagnostic and therapeutic applications for senescence‐associated disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“One approach stems from the increase in lysosomal mass and senescence-associated β-galactosidase activity in many senescent cells, whereby galacto-oligosaccharide-coated nanoparticles and β-galactosidase-activated prodrugs appear to eliminate at least some of these cells92,93.”
From Cellular senescence and senolytics: the path to the clinic (2022) · cites this paper as [92]
The cited source says what the claim attributes to it.
In the citing paper
“Nanoparticles containing either fluorophores or cytotoxic agents coated with galacto-oligosaccharides were found to preferentially deliver cytotoxic cargo to senescent cells because of the higher level of SA-β-gal activity in these cells218.”
From Cellular senescence in ageing: from mechanisms to therapeutic opportunities (2021) · cites this paper as [218]
The cited source says what the claim attributes to it.
In the citing paper
“A senescence transcriptional signature could enable rapid detection of senescent cells, and multiple such gene sets have been described132–136,139.”
From Guidelines for minimal information on cellular senescence experimentation in vivo (2024) · cites this paper as [134]
The cited source says what the claim attributes to it.
In the citing paper
“Galacto-oligosaccharide encapsulated nanoparticles (GalNP) containing cytotoxic or senolytic drugs (Muñoz-Espín et al. 2018) and galactose-derived prodrugs display senolytic properties (González-Gualda et al. 2020; Guerrero et al. 2020)”
From Senescence and the SASP: many therapeutic avenues (2020) · cites this paper as Muñoz-Espín et al. 2018
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Spatial omics has not yet been used extensively for senescence research but is in development132–136.”
From Guidelines for minimal information on cellular senescence experimentation in vivo (2024) · cites this paper as [134]
Experimental — accuracy not yet measured
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
Love, M. I., Huber, W., & Anders, S. (2014) · Genome Biology · doi:10.1186/s13059-014-0550-8 · Cited by 95,106 · cited 1×
“0.10 (Trapnell et al, 2012), Bowtie 1.0.0 (Langmead et al, 2009) and Samtools 0.1.19.0 (Li et al, 2009); and transcripts assembly, abundances estimation, and differential expression were calculated with DESeq2 (Love et al, 2014).”
InfluentialThe Sequence Alignment/Map format and SAMtools
Li, H., Handsaker, B., Wysoker, A., Fennell, T., Ruan, J., Homer, N., Marth, G., Abecasis, G., Durbin, R., & 1000 Genome Project Data Processing Subgroup (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp352 · Cited by 62,041 · cited 1×
“0.10 (Trapnell et al, 2012), Bowtie 1.0.0 (Langmead et al, 2009) and Samtools 0.1.19.0 (Li et al, 2009); and transcripts assembly, abundances estimation, and differential expression were calculated with DESeq2 (Love et al, 2014).”
MethodInfluentialUltrafast and memory-efficient alignment of short DNA sequences to the human genome.
Langmead, B., Trapnell, C., Pop, M., & Salzberg, S. L. (2009) · Genome Biology · doi:10.1186/gb-2009-10-3-r25 · Cited by 21,849 · cited 1×
“0.10 (Trapnell et al, 2012), Bowtie 1.0.0 (Langmead et al, 2009) and Samtools 0.1.19.0 (Li et al, 2009); and transcripts assembly, abundances estimation, and differential expression were calculated with DESeq2 (Love et al, 2014).”
MethodInfluentialOrdered mesoporous molecular sieves synthesized by a liquid-crystal template mechanism
Kresge, C. T., Leonowicz, M. E., Roth, W. J., Vartuli, J. C., & Beck, J. S. (1992) · Nature · doi:10.1038/359710a0 · Cited by 16,275 · cited 4×
“For the synthesis of the mesoporous silica MCM-41 scaffolds (Kresge et al, 1992), N-cetyltrimethylammonium bromide (CTAB, Sigma, #H6269) was first dissolved in 480 ml of deionized water at 2.74 mM.”
BackgroundMethodInfluentialTrapnell, C., Roberts, A., Goff, L., Pertea, G., Kim, D., Kelley, D. R., Pimentel, H., Salzberg, S. L., Rinn, J. L., & Pachter, L. (2012) · Nature Protocols · doi:10.1038/nprot.2012.016 · Cited by 12,116 · cited 1×
“0.10 (Trapnell et al, 2012), Bowtie 1.0.0 (Langmead et al, 2009) and Samtools 0.1.19.0 (Li et al, 2009); and transcripts assembly, abundances estimation, and differential expression were calculated with DESeq2 (Love et al, 2014).”
MethodInfluentialA biomarker that identifies senescent human cells in culture and in aging skin in vivo.
Dimri, G. P., Lee, X., Basile, G., Acosta, M., Scott, G., Roskelley, C., Medrano, E. E., Linskens, M., Rubelj, I., & Pereira-Smith, O. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9363 · Cited by 7,477
Analysis of nanoparticle delivery to tumours
Wilhelm, S., Tavares, A. J., Dai, Q., Ohta, S., Audet, J., Dvorak, H. F., & Chan, W. C. W. (2016) · Nature Reviews Materials · doi:10.1038/natrevmats.2016.14 · Cited by 5,218 · cited 1×
“In this regard, it is relevant to mention that macrophages are known to metabolize nanoparticles (Wilhelm et al, 2016) and can present SAbGal activity without actually being senescent (Hall et al, 2017).”
BackgroundNaturally occurring p16Ink4a-positive cells shorten healthy lifespan
Baker, D. J., Childs, B. G., Durik, M., Wijers, M. E., Sieben, C. J., Zhong, J., A. Saltness, R., Jeganathan, K. B., Verzosa, G. C., Pezeshki, A., et al. (2016) · Nature · doi:10.1038/nature16932 · Cited by 2,876 · cited 1×
“Published under the terms of the CC BY 4.0 license EMBO Molecular Medicine 10: e9355 | 2018 1 of 18 processes associated with chemotherapy, and extends longevity (Baker et al, 2016; Childs et al, 2016; Demaria et al, 2017).”
MethodInfluentialCellular senescence: from physiology to pathology
Muñoz-Espín, D., & Serrano, M. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3823 · Cited by 2,818
Self-citationThe Achilles' heel of senescent cells: from transcriptome to senolytic drugs
Zhu, Y., Tchkonia, T., Pirtskhalava, T., Gower, A. C., Ding, H., Giorgadze, N., Palmer, A. K., Ikeno, Y., Hubbard, G. B., Lenburg, M., et al. (2015) · Aging Cell · doi:10.1111/acel.12344 · Cited by 2,584 · cited 3×
“Importantly, senescent cells present vulnerabilities to particular small molecule inhibitors, known as “senolytics”, that trigger apoptosis preferentially in senescent cells (Zhu et al, 2015).”
BackgroundGewirtz, D. (1999) · Biochemical Pharmacology · doi:10.1016/s0006-2952(98)00307-4 · Cited by 2,240 · cited 1×
“In this regard, it is important to point out that doxorubicin kills cells through multiple mechanisms, many of which are not related to cell division (Gewirtz, 1999).”
BackgroundAn Essential Role for Senescent Cells in Optimal Wound Healing through Secretion of PDGF-AA
Demaria, M., Ohtani, N., Youssef, S. A., Rodier, F., Toussaint, W., Mitchell, J. R., Laberge, R.-M., Vijg, J., Van Steeg, H., Dollé, M. E. T., et al. (2014) · Developmental Cell · doi:10.1016/j.devcel.2014.11.012 · Cited by 2,045 · cited 1×
“…of inflammatory cells, the dismissal of senescent cells by phagocytic and immune cells, and the activation of stem/progenitor features in non-damaged surrounding cells (Krizhanovsky et al, 2008; Demaria et al, 2014; Yun et al, 2015; Mosteiro et al, 2016; Chiche et al, 2017; Ritschka et al, 2017).”
Senescence of Activated Stellate Cells Limits Liver Fibrosis
Krizhanovsky, V., Yon, M., Dickins, R. A., Hearn, S., Simon, J., Miething, C., Yee, H., Zender, L., & Lowe, S. W. (2008) · Cell · doi:10.1016/j.cell.2008.09.015 · Cited by 2,027 · cited 1×
“…of inflammatory cells, the dismissal of senescent cells by phagocytic and immune cells, and the activation of stem/progenitor features in non-damaged surrounding cells (Krizhanovsky et al, 2008; Demaria et al, 2014; Yun et al, 2015; Mosteiro et al, 2016; Chiche et al, 2017; Ritschka et al, 2017).”
Clearance of senescent cells by ABT263 rejuvenates aged hematopoietic stem cells in mice
Chang, J., Wang, Y., Shao, L., Laberge, R.-M., Demaria, M., Campisi, J., Janakiraman, K., Sharpless, N. E., Ding, S., Feng, W., et al. (2016) · Nature Medicine · doi:10.1038/nm.4010 · Cited by 1,819 · cited 1×
“Cardiotoxicity is the most serious side effect of doxorubicin (Chatterjee et al, 2010), whereas thrombocytopenia is the main toxicity of navitoclax (Kile, 2014).”
BackgroundCellular senescence mediates fibrotic pulmonary disease
Schafer, M. J., White, T. A., Iijima, K., Haak, A. J., Ligresti, G., Atkinson, E. J., Oberg, A. L., Birch, J., Salmonowicz, H., Zhu, Y., et al. (2017) · Nature Communications · doi:10.1038/ncomms14532 · Cited by 1,613 · cited 3×
“…gal-encapsulated fluorophores in pulmonary fibrosis Cellular senescence is abundant in pulmonary fibrosis, both in humans and in mice, and actively contributes to the pathological manifestations of this disease (Aoshiba et al, 2003, 2013; Hecker et al, 2014; Pan et al, 2017; Schafer et al, 2017).”
BackgroundBaar, M. P., Brandt, R. M. C., Putavet, D. A., Klein, J. D. D., Derks, K. W. J., Bourgeois, B. R. M., Stryeck, S., Rijksen, Y., van Willigenburg, H., Feijtel, D. A., et al. (2017) · Cell · doi:10.1016/j.cell.2017.02.031 · Cited by 1,454 · cited 2×
“Similarly, inactivation of the transcription factor FOXA4 with a peptide derivative preferentially eliminates senescent cells over non-senescent ones (Baar et al, 2017).”
BackgroundSenescence-associated β-galactosidase is lysosomal β-galactosidase.
Lee, B. Y., Han, J. A., Im, J. S., Morrone, A., Johung, K., Goodwin, E. C., Kleijer, W. J., DiMaio, D., & Hwang, E. S. (2006) · Aging Cell · doi:10.1111/j.1474-9726.2006.00199.x · Cited by 1,444 · cited 1×
“Senescent cells in vitro are characterized by high levels of lysosomal b-galactosidase activity, known as senescence-associated bgalactosidase (SAbGal; Dimri et al, 1995; Muñoz-Espı́n & Serrano, 2014; Kurz et al, 2000; Lee et al, 2006).”
BackgroundProgrammed cell senescence during mammalian embryonic development
Muñoz-Espín, D., Cañamero, M., Maraver, A., Gómez-López, G., Contreras, J., Murillo-Cuesta, S., Rodríguez-Baeza, A., Varela-Nieto, I., Ruberte, J., Collado, M., et al. (2013) · Cell · doi:10.1016/j.cell.2013.10.019 · Cited by 1,428
Self-citationCellular senescence promotes adverse effects of chemotherapy and cancer relapse
Demaria, M., O'Leary, M. N., Chang, J., Shao, L., Liu, S., Alimirah, F., Koenig, K., Le, C., Mitin, N., Deal, A. M., et al. (2017) · Cancer Discovery · doi:10.1158/2159-8290.cd-16-0241 · Cited by 1,338 · cited 1×
“Published under the terms of the CC BY 4.0 license EMBO Molecular Medicine 10: e9355 | 2018 1 of 18 processes associated with chemotherapy, and extends longevity (Baker et al, 2016; Childs et al, 2016; Demaria et al, 2017).”
MethodInfluentialSenescent cells: an emerging target for diseases of ageing
Childs, B. G., Gluscevic, M., Baker, D. J., Laberge, R.-M., Marquess, D., Dananberg, J., & van Deursen, J. M. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.116 · Cited by 1,284
Senescent intimal foam cells are deleterious at all stages of atherosclerosis
Childs, B. G., Baker, D. J., Wijshake, T., Conover, C. A., Campisi, J., & van Deursen, J. M. (2016) · Science · doi:10.1126/science.aaf6659 · Cited by 1,195 · cited 1×
“Published under the terms of the CC BY 4.0 license EMBO Molecular Medicine 10: e9355 | 2018 1 of 18 processes associated with chemotherapy, and extends longevity (Baker et al, 2016; Childs et al, 2016; Demaria et al, 2017).”
MethodInfluentialSenescence is a developmental mechanism that contributes to embryonic growth and patterning
Storer, M., Mas, A., Robert-Moreno, A., Pecoraro, M., Ortells, M. C., Di Giacomo, V., Yosef, R., Pilpel, N., Krizhanovsky, V., Sharpe, J., et al. (2013) · Cell · doi:10.1016/j.cell.2013.10.041 · Cited by 1,186 · cited 1×
“Even during vertebrate development, embryos use senescence in a damage-independent manner to initiate specific tissue remodeling processes (Muñoz-Espı́n et al, 2013; Storer et al, 2013).”
BackgroundZhu, Y., Tchkonia, T., Fuhrmann‐Stroissnigg, H., Dai, H. M., Ling, Y. Y., Stout, M. B., Pirtskhalava, T., Giorgadze, N., Johnson, K. O., Giles, C. B., et al. (2016) · Aging Cell · doi:10.1111/acel.12445 · Cited by 1,148 · cited 3×
“…decided to test this strategy in vivo using gal-encapsulated doxorubicin and also gal-encapsulated navitoclax (also known as ABT-263), which is one of the most efficient senolytic compounds reported to date (Zhu et al, 2016; Chang et al, 2016; Yosef et al, 2016; Pan et al, 2017; Appendix Fig S1E).”
BackgroundMethodSenescence in tumours: evidence from mice and humans
Collado, M., & Serrano, M. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2772 · Cited by 1,124 · cited 1×
“…of inflammatory cells, the dismissal of senescent cells by phagocytic and immune cells, and the activation of stem/progenitor features in non-damaged surrounding cells (Krizhanovsky et al, 2008; Demaria et al, 2014; Yun et al, 2015; Mosteiro et al, 2016; Chiche et al, 2017; Ritschka et al, 2017).”
BackgroundSelf-citationForging a signature of in vivo senescence
Sharpless, N. E., & Sherr, C. J. (2015) · Nature Reviews Cancer · doi:10.1038/nrc3960 · Cited by 1,104 · cited 2×
“Interestingly, damaged or diseased tissues generally contain cells that are positive for SAbGal, while normal healthy tissues are negative for this marker (Sharpless & Sherr, 2015).”
BackgroundChatterjee, K., Zhang, J., Honbo, N., & Karliner, J. S. (2010) · Cardiology · doi:10.1159/000265166 · Cited by 1,065
Directed elimination of senescent cells by inhibition of BCL-W and BCL-XL
Yosef, R., Pilpel, N., Tokarsky-Amiel, R., Biran, A., Ovadya, Y., Cohen, S., Vadai, E., Dassa, L., Shahar, E., Condiotti, R., et al. (2016) · Nature Communications · doi:10.1038/ncomms11190 · Cited by 1,032 · cited 3×
“…decided to test this strategy in vivo using gal-encapsulated doxorubicin and also gal-encapsulated navitoclax (also known as ABT-263), which is one of the most efficient senolytic compounds reported to date (Zhu et al, 2016; Chang et al, 2016; Yosef et al, 2016; Pan et al, 2017; Appendix Fig S1E).”
BackgroundMethodKurz, D. J., Decary, S., Hong, Y., & Erusalimsky, J. D. (2000) · Journal of Cell Science · doi:10.1242/jcs.113.20.3613 · Cited by 899
Slowing, I., Trewyn, B. G., & Lin, V. S.-Y. (2006) · Journal of the American Chemical Society · doi:10.1021/ja0645943 · Cited by 846 · cited 1×
“…scaffold known as MCM-41 (Kresge et al, 1992), are efficiently internalized into cells by endocytosis, targeted to the lysosomes, and eventually released by exocytosis (Slowing et al, 2006, 2011; Tao et al, 2009; Bernardos et al, 2010; Hocine et al, 2010; Yanes et al, 2013; Aznar et al, 2016).”
BackgroundRoos, C. M., Zhang, B., Palmer, A. K., Ogrodnik, M. B., Pirtskhalava, T., Thalji, N. M., Hagler, M., Jurk, D., Smith, L. A., Casaclang‐Verzosa, G., et al. (2016) · Aging Cell · doi:10.1111/acel.12458 · Cited by 738 · cited 1×
“These pharmacological treatments reduce the number of senescent cells in vivo and show therapeutic activity against senescence-associated diseases and aging (Zhu et al, 2015, 2016; Chang et al, 2016; Roos et al, 2016; Yosef et al, 2016; Baar et al, 2017; Pan et al, 2017; Schafer et al, 2017).”
BackgroundReversal of persistent fibrosis in aging by targeting Nox4-Nrf2 redox imbalance
Hecker, L., Logsdon, N. J., Kurundkar, D., Kurundkar, A., Bernard, K., Hock, T., Meldrum, E., Sanders, Y. Y., & Thannickal, V. J. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3008182 · Cited by 686 · cited 1×
“…gal-encapsulated fluorophores in pulmonary fibrosis Cellular senescence is abundant in pulmonary fibrosis, both in humans and in mice, and actively contributes to the pathological manifestations of this disease (Aoshiba et al, 2003, 2013; Hecker et al, 2014; Pan et al, 2017; Schafer et al, 2017).”
BackgroundThe senescence-associated secretory phenotype induces cellular plasticity and tissue regeneration.
Ritschka, B., Storer, M., Mas, A., Heinzmann, F., Ortells, M. C., Morton, J. P., Sansom, O. J., Zender, L., & Keyes, W. M. (2017) · Genes & Development · doi:10.1101/gad.290635.116 · Cited by 650 · cited 1×
“…of inflammatory cells, the dismissal of senescent cells by phagocytic and immune cells, and the activation of stem/progenitor features in non-damaged surrounding cells (Krizhanovsky et al, 2008; Demaria et al, 2014; Yun et al, 2015; Mosteiro et al, 2016; Chiche et al, 2017; Ritschka et al, 2017).”
BackgroundSpatial Coupling of mTOR and Autophagy Augments Secretory Phenotypes
Narita, M., Young, A. R. J., Arakawa, S., Samarajiwa, S. A., Nakashima, T., Yoshida, S., Hong, S., Berry, L. S., Reichelt, S., Ferreira, M., et al. (2011) · Science · doi:10.1126/science.1205407 · Cited by 594
Tissue damage and senescence provide critical signals for cellular reprogramming in vivo
Mosteiro, L., Pantoja, C., Alcazar, N., Marión, R. M., Chondronasiou, D., Rovira, M., Fernandez-Marcos, P. J., Muñoz-Martin, M., Blanco-Aparicio, C., Pastor, J., et al. (2016) · Science · doi:10.1126/science.aaf4445 · Cited by 589 · cited 1×
“…of inflammatory cells, the dismissal of senescent cells by phagocytic and immune cells, and the activation of stem/progenitor features in non-damaged surrounding cells (Krizhanovsky et al, 2008; Demaria et al, 2014; Yun et al, 2015; Mosteiro et al, 2016; Chiche et al, 2017; Ritschka et al, 2017).”
BackgroundSelf-citationLysosome-mediated processing of chromatin in senescence
Ivanov, A., Pawlikowski, J., Manoharan, I., van Tuyn, J., Nelson, D. M., Rai, T. S., Shah, P. P., Hewitt, G., Korolchuk, V. I., Passos, J. F., et al. (2013) · Journal of Cell Biology · doi:10.1083/jcb.201212110 · Cited by 539 · cited 1×
“Indeed, senescent cells show a remarkable accumulation of lysosomes, together with abnormal endosomal traffic and autophagy (Cho et al, 2011; Narita et al, 2011; Ivanov et al, 2013; Udono et al, 2015; Tai et al, 2017).”
BackgroundGated Materials for On-Command Release of Guest Molecules
Aznar, E., Oroval, M., Pascual, L., Murguía, J. R., Martínez-Máñez, R., & Sancenón, F. (2016) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00456 · Cited by 488 · cited 1×
“…scaffold known as MCM-41 (Kresge et al, 1992), are efficiently internalized into cells by endocytosis, targeted to the lysosomes, and eventually released by exocytosis (Slowing et al, 2006, 2011; Tao et al, 2009; Bernardos et al, 2010; Hocine et al, 2010; Yanes et al, 2013; Aznar et al, 2016).”
BackgroundSelf-citationMutation analysis of 24 known cancer genes in the NCI-60 cell line set
Ikediobi, O. N., Davies, H., Bignell, G., Edkins, S., Stevens, C., O'Meara, S., Santarius, T., Avis, T., Barthorpe, S., Brackenbury, L., et al. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0433 · Cited by 440 · cited 1×
“Of note, the three cell lines used, SK-MEL103, NCI-H226, and UT-SCC-42B, have an active retinoblastoma pathway (RB1-proficient; Ikediobi et al, 2006; Giefing et al, 2011; Massaro et al, 2017) and undergo senescence upon treatment with palbociclib (Fig 1B and Appendix Fig S1F).”
MethodSenescence-associated inflammatory responses: aging and cancer perspectives
Lasry, A., & Ben-Neriah, Y. (2015) · Trends in Immunology · doi:10.1016/j.it.2015.02.009 · Cited by 408 · cited 2×
“E GSEA plots of published signatures of SASP and SIR (senescence-inflammatory response) (Lasry & Ben-Neriah, 2015) against the ranked list of differential expression between Rho+ and Rho cells (all CD45 CD31 ) from bleomycin-treated mice (n = 3), at 2 weeks post-bleomycin, as in (D).”
BackgroundMethodHall, B. M., Balan, V., Gleiberman, A. S., Strom, E., Krasnov, P., Virtuoso, L. P., Rydkina, E., Vujcic, S., Balan, K., Gitlin, I. I., et al. (2017) · Aging · doi:10.18632/aging.101268 · Cited by 407
Recurrent turnover of senescent cells during regeneration of a complex structure
Yun, M. H., Davaapil, H., & Brockes, J. P. (2015) · eLife · doi:10.7554/elife.05505 · Cited by 385 · cited 1×
“…of inflammatory cells, the dismissal of senescent cells by phagocytic and immune cells, and the activation of stem/progenitor features in non-damaged surrounding cells (Krizhanovsky et al, 2008; Demaria et al, 2014; Yun et al, 2015; Mosteiro et al, 2016; Chiche et al, 2017; Ritschka et al, 2017).”
BackgroundTai, H., Wang, Z., Gong, H., Han, X., Zhou, J., Wang, X., Wei, X., Ding, Y., Huang, N., Qin, J., et al. (2017) · Autophagy · doi:10.1080/15548627.2016.1247143 · Cited by 334 · cited 1×
“Indeed, senescent cells show a remarkable accumulation of lysosomes, together with abnormal endosomal traffic and autophagy (Cho et al, 2011; Narita et al, 2011; Ivanov et al, 2013; Udono et al, 2015; Tai et al, 2017).”
BackgroundBernardos, A., Mondragón, L., Aznar, E., Marcos, M. D., Martínez-Máñez, R., Sancenón, F., Soto, J., Barat, J. M., Pérez-Payá, E., Guillem, C., et al. (2010) · ACS Nano · doi:10.1021/nn101499d · Cited by 310 · cited 1×
“…scaffold known as MCM-41 (Kresge et al, 1992), are efficiently internalized into cells by endocytosis, targeted to the lysosomes, and eventually released by exocytosis (Slowing et al, 2006, 2011; Tao et al, 2009; Bernardos et al, 2010; Hocine et al, 2010; Yanes et al, 2013; Aznar et al, 2016).”
BackgroundSelf-citationMolecular regulation of cardiac hypertrophy
Barry, S. P., Davidson, S. M., & Townsend, P. A. (2008) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2008.02.020 · Cited by 306 · cited 1×
“For doxorubicintreated mice, we measured the mRNA levels of Myh7 and Nppa, which reflect cardiac hypertrophy in response to doxorubicininduced cardiomyocyte death (Barry et al, 2008; Richard et al, 2011).”
MethodInjury-Induced Senescence Enables In Vivo Reprogramming in Skeletal Muscle
Chiche, A., Le Roux, I., von Joest, M., Sakai, H., Aguín, S. B., Cazin, C., Salam, R., Fiette, L., Alegria, O., Flamant, P., et al. (2017) · Cell Stem Cell · doi:10.1016/j.stem.2016.11.020 · Cited by 295 · cited 1×
“…of inflammatory cells, the dismissal of senescent cells by phagocytic and immune cells, and the activation of stem/progenitor features in non-damaged surrounding cells (Krizhanovsky et al, 2008; Demaria et al, 2014; Yun et al, 2015; Mosteiro et al, 2016; Chiche et al, 2017; Ritschka et al, 2017).”
BackgroundPan, J., Li, D., Xu, Y., Zhang, J., Wang, Y., Chen, M., Lin, S., Huang, L., Chung, E. J., Citrin, D. E., et al. (2017) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2017.02.216 · Cited by 242 · cited 5×
“…decided to test this strategy in vivo using gal-encapsulated doxorubicin and also gal-encapsulated navitoclax (also known as ABT-263), which is one of the most efficient senolytic compounds reported to date (Zhu et al, 2016; Chang et al, 2016; Yosef et al, 2016; Pan et al, 2017; Appendix Fig S1E).”
BackgroundMethodInfluentialBleomycin induces cellular senescence in alveolar epithelial cells
Aoshiba, K., Tsuji, T., & Nagai, A. (2003) · European Respiratory Journal · doi:10.1183/09031936.03.00011903 · Cited by 197 · cited 1×
“…gal-encapsulated fluorophores in pulmonary fibrosis Cellular senescence is abundant in pulmonary fibrosis, both in humans and in mice, and actively contributes to the pathological manifestations of this disease (Aoshiba et al, 2003, 2013; Hecker et al, 2014; Pan et al, 2017; Schafer et al, 2017).”
BackgroundTherapeutic interventions for aging: the case of cellular senescence
Soto-Gamez, A., & Demaria, M. (2017) · Drug Discovery Today · doi:10.1016/j.drudis.2017.01.004 · Cited by 192 · cited 1×
“In recent years, it has become evident that multiple diseases are associated with the presence of senescent cells and that the elimination of these cells has therapeutic benefits in mouse models (Childs et al, 2017; Soto-Gamez & Demaria, 2017).”
BackgroundTargeted Cargo Delivery in Senescent Cells Using Capped Mesoporous Silica Nanoparticles
Agostini, A., Mondragón, L., Bernardos, A., Martínez‐Máñez, R., Marcos, M. D., Sancenón, F., Soto, J., Costero, A., Manguan‐García, C., Perona, R., et al. (2012) · Angewandte Chemie International Edition · doi:10.1002/anie.201204663 · Cited by 166 · cited 5×
“In a previous work (Agostini et al, 2012), we designed beads pre-loaded with a fluorophore and then coated with a layer of galacto-oligosaccharides of mixed lengths (referred to as GosNP).”
BackgroundMethodInfluentialSelf-citationYanes, R. E., Tarn, D., Hwang, A. A., Ferris, D. P., Sherman, S. P., Thomas, C. R., Lu, J., Pyle, A. D., Zink, J. I., & Tamanoi, F. (2013) · Small · doi:10.1002/smll.201201811 · Cited by 163
Festing, M., Overend, P., Das, R., Cortina‐Borja, M., & Berdoy, M. (2002) · Cited by 140
Mesoporosity and Functional Group Dependent Endocytosis and Cytotoxicity of Silica Nanomaterials
Tao, Z., Toms, B. B., Goodisman, J., & Asefa, T. (2009) · Chemical Research in Toxicology · doi:10.1021/tx900276u · Cited by 134 · cited 1×
“…scaffold known as MCM-41 (Kresge et al, 1992), are efficiently internalized into cells by endocytosis, targeted to the lysosomes, and eventually released by exocytosis (Slowing et al, 2006, 2011; Tao et al, 2009; Bernardos et al, 2010; Hocine et al, 2010; Yanes et al, 2013; Aznar et al, 2016).”
BackgroundThe role of apoptosis in megakaryocytes and platelets
Kile, B. T. (2014) · British Journal of Haematology · doi:10.1111/bjh.12757 · Cited by 122 · cited 1×
“Cardiotoxicity is the most serious side effect of doxorubicin (Chatterjee et al, 2010), whereas thrombocytopenia is the main toxicity of navitoclax (Kile, 2014).”
BackgroundLi, W., Fan, J., Hochhauser, D., Banerjee, D., Zielinski, Z., Almasan, A., Yin, Y., Kelly, R., Wahl, G. M., & Bertino, J. R. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.22.10436 · Cited by 109 · cited 1×
“These cells are null for the RB1 gene (Li et al, 1995) and, therefore, are resistant to palbociclib.”
BackgroundSenescence-associated secretory phenotype in a mouse model of bleomycin-induced lung injury
Aoshiba, K., Tsuji, T., Kameyama, S., Itoh, M., Semba, S., Yamaguchi, K., & Nakamura, H. (2013) · Experimental and Toxicologic Pathology · doi:10.1016/j.etp.2013.04.001 · Cited by 100 · cited 1×
“…gal-encapsulated fluorophores in pulmonary fibrosis Cellular senescence is abundant in pulmonary fibrosis, both in humans and in mice, and actively contributes to the pathological manifestations of this disease (Aoshiba et al, 2003, 2013; Hecker et al, 2014; Pan et al, 2017; Schafer et al, 2017).”
BackgroundSilicalites and Mesoporous Silica Nanoparticles for photodynamic therapy
Hocine, O., Gary‐Bobo, M., Brevet, D., Maynadier, M., Fontanel, S., Raehm, L., Richeter, S., Loock, B., Couleaud, P., & Frochot, C. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.10.004 · Cited by 93 · cited 1×
“…scaffold known as MCM-41 (Kresge et al, 1992), are efficiently internalized into cells by endocytosis, targeted to the lysosomes, and eventually released by exocytosis (Slowing et al, 2006, 2011; Tao et al, 2009; Bernardos et al, 2010; Hocine et al, 2010; Yanes et al, 2013; Aznar et al, 2016).”
BackgroundSlowing, I. I., Vivero‐Escoto, J. L., Zhao, Y., Kandel, K., Peeraphatdit, C., Trewyn, B. G., & Lin, V. S. ‐. (2011) · Small · doi:10.1002/smll.201002077 · Cited by 90 · cited 1×
“…scaffold known as MCM-41 (Kresge et al, 1992), are efficiently internalized into cells by endocytosis, targeted to the lysosomes, and eventually released by exocytosis (Slowing et al, 2006, 2011; Tao et al, 2009; Bernardos et al, 2010; Hocine et al, 2010; Yanes et al, 2013; Aznar et al, 2016).”
BackgroundGiefing, M., Zemke, N., Brauze, D., Kostrzewska‐Poczekaj, M., Luczak, M., Szaumkessel, M., Pelinska, K., Kiwerska, K., Tönnies, H., Grenman, R., et al. (2011) · Genes, Chromosomes and Cancer · doi:10.1002/gcc.20840 · Cited by 61 · cited 1×
“Of note, the three cell lines used, SK-MEL103, NCI-H226, and UT-SCC-42B, have an active retinoblastoma pathway (RB1-proficient; Ikediobi et al, 2006; Giefing et al, 2011; Massaro et al, 2017) and undergo senescence upon treatment with palbociclib (Fig 1B and Appendix Fig S1F).”
MethodRichard, C., Ghibu, S., Delemasure, S., Guilland, J.-C., Rosiers, C. D., Zeller, M., Cottin, Y., Rochette, L., & Vergely, C. (2011) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.111.185892 · Cited by 56 · cited 1×
“For doxorubicintreated mice, we measured the mRNA levels of Myh7 and Nppa, which reflect cardiac hypertrophy in response to doxorubicininduced cardiomyocyte death (Barry et al, 2008; Richard et al, 2011).”
MethodAlteration of Golgi structure in senescent cells and its regulation by a G protein γ subunit
Cho, J.-H., Saini, D. K., Karunarathne, W. K. A., Kalyanaraman, V., & Gautam, N. (2011) · Cellular Signalling · doi:10.1016/j.cellsig.2011.01.001 · Cited by 46 · cited 1×
“In addition, cellular senescence is a defining feature of a wide variety of premalignant lesions both in humans and in mice (Collado & Serrano, 2010).”
BackgroundUdono, M., Fujii, K., Harada, G., Tsuzuki, Y., Kadooka, K., Zhang, P., Fujii, H., Amano, M., Nishimura, S., Tashiro, K., et al. (2015) · Scientific Reports · doi:10.1038/srep17342 · Cited by 35 · cited 1×
“Indeed, senescent cells show a remarkable accumulation of lysosomes, together with abnormal endosomal traffic and autophagy (Cho et al, 2011; Narita et al, 2011; Ivanov et al, 2013; Udono et al, 2015; Tai et al, 2017).”
BackgroundMassaro, R. R., Faião‐Flores, F., Rebecca, V. W., Sandri, S., Alves-Fernandes, D. K., Pennacchi, P. C., Smalley, K. S. M., & Maria–Engler, S. S. (2017) · Pharmacological Research · doi:10.1016/j.phrs.2017.02.013 · Cited by 34 · cited 1×
“Of note, the three cell lines used, SK-MEL103, NCI-H226, and UT-SCC-42B, have an active retinoblastoma pathway (RB1-proficient; Ikediobi et al, 2006; Giefing et al, 2011; Massaro et al, 2017) and undergo senescence upon treatment with palbociclib (Fig 1B and Appendix Fig S1F).”
MethodSheng, Y., Xu, J., You, Y., Xu, F., & Chen, Y. (2015) · Molecular Pharmaceutics · doi:10.1021/mp500386y · Cited by 30 · cited 2×
“It is known that modified forms of doxorubicin with lysosomal tropism efficiently induce apoptosis (Nair et al, 2015; Sheng et al, 2015).”
BackgroundNair, J. B., Mohapatra, S., Ghosh, S., & Maiti, K. K. (2014) · Chemical Communications · doi:10.1039/c4cc09829c · Cited by 28 · cited 2×
“It is known that modified forms of doxorubicin with lysosomal tropism efficiently induce apoptosis (Nair et al, 2015; Sheng et al, 2015).”
BackgroundKnaś, M., Zalewska, A., Krętowski, R., Niczyporuk, M., Waszkiewicz, N., Cechowska-Pasko, M., Waszkiel, D., & Zwierz, K. (2012) · Folia Histochemica et Cytobiologica · doi:10.5603/fhc.2012.0031 · Cited by 23
Cited by
Cellular senescence in ageing: from mechanisms to therapeutic opportunities
Di Micco, R., Krizhanovsky, V., Baker, D., & d’Adda di Fagagna, F. (2021) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-020-00314-w · Cited by 2,277
Senolytic drugs: from discovery to translation
Kirkland, J. L., & Tchkonia, T. (2020) · Journal of Internal Medicine · doi:10.1111/joim.13141 · Cited by 1,227
Senescence and the SASP: many therapeutic avenues
Birch, J., & Gil, J. (2020) · Genes & Development · doi:10.1101/gad.343129.120 · Cited by 1,177
Cellular senescence and senolytics: the path to the clinic
Chaib, S., Tchkonia, T., & Kirkland, J. L. (2022) · Nature Medicine · doi:10.1038/s41591-022-01923-y · Cited by 1,134
Self-citationExploiting senescence for the treatment of cancer
Wang, L., Lankhorst, L., & Bernards, R. (2022) · Nature Reviews Cancer · doi:10.1038/s41568-022-00450-9 · Cited by 867
Metadata
- Authors
- Muñoz‐Espín, D., Rovira, M., Galiana, I., Giménez, C., Lozano‐Torres, B., Paez‐Ribes, M., Llanos, S., Chaib, S., Muñoz‐Martín, M., Ucero, A. C., Garaulet, G., Mulero, F., Dann, S. G., VanArsdale, T., Shields, D. J., Bernardos, A., Murguía, J. R., Martínez‐Máñez, R., & Serrano, M.
- Affiliations
- University of Cambridge (GB)
- Spanish National Cancer Research Centre (ES)
- Universitat de València (ES)
- Pfizer (United States) (US)
- Institució Catalana de Recerca i Estudis Avançats (ES)
- Corresponding author
- Muñoz‐Espín, Daniel
- Serrano, Manuel
- ORCID
- Venue
- EMBO Molecular Medicine
- Published
- 2018-07-16
- Volume
- 10
- Issue
- 9
- ISSN
- 1757-4676 (ISSN-L)
- 1757-4684
- PMC
- PMC6127887
- OpenAlex
- W2884253843
- Cited by
- 339
- References
- 64
- Citations by year
- 2026: 33 · 2025: 48 · 2024: 52 · 2023: 45 · 2022: 48 · 2021: 28 · 2020: 52 · 2019: 31 · 2018: 2
- FWCI
- 19.37
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor)
- Locations
- EMBO Molecular Medicine (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, other-oa)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- RiuNet (Universitat Politècnica de València) (submittedVersion, cc-by-nc-nd)
- Apollo (University of Cambridge) (submittedVersion, cc-by)
- Apollo (cc-by)
- Funders
- Secretaría de Estado de Investigación, Desarrollo e Innovación (MAT2015‐64139‐C4‐1‐R)
- H2020 European Research Council
- Instituto de Salud Carlos III (DTS16/00205)
- European Regional Development Fund
- European Social Fund
- Institut Ruđer Bošković
- Fundación Botín
- Banco Santander
- “la Caixa” Foundation
- Cancer Research UK (C9685‐A25177, RG86786)
- Generalitat Valenciana (PROMETEOII/2014/047)
- Pfizer
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Keywords
- senolytics, senescent cells, drug delivery systems, galactooligosaccharides, lysosomal beta-galactosidase, chemotherapy-induced senescence, palbociclib, age-related diseases
- MeSH terms
- Animals, beta-Galactosidase, Cell Survival, Cytotoxins, Disease Models, Animal, Drug Compounding, Fluorescent Dyes, Galactose, Lysosomes, Neoplasm Transplantation, Neoplasms, Oligosaccharides, Piperazines, Pyridines, Staining and Labeling, Drug Delivery Systems, Cellular Senescence, Mice, Heterografts
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.